-
I've made a fortune! Novo Nordisk announces Q4 financial report. Weight loss drug Wegovy's annual revenue has doubled
European pharmaceutical giant Novo Nordisk released its Q4 2023 financial report on Wednesday, with its revenue performance exceeding market expectations. It also predicts that it will continue to ac ...- centery0918112
- 2024-1-31 17:41
- 支持
- 反对
- 回复
- 收藏